Clinical Trial Update: Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury [NA]

View source ↗

Summary

A clinical trial update on efficacy of glucagon-like peptide-1 for reperfusion injury in acute myocardial infarction; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Glucagonlike peptide-1 (glucagon-like peptide-1)

Snippet

Sponsor: Chen Wei Ren, MD | Conditions: Acute Myocardial Infarction | NA | Status: UNKNOWN